These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22638868)

  • 1. Effect of compression on non-isothermal crystallization behaviour of amorphous indomethacin.
    Ayenew Z; Paudel A; Rombaut P; Van den Mooter G
    Pharm Res; 2012 Sep; 29(9):2489-98. PubMed ID: 22638868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
    Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
    Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin.
    Priemel PA; Grohganz H; Gordon KC; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2012 Sep; 82(1):187-93. PubMed ID: 22683936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial confinement can lead to increased stability of amorphous indomethacin.
    Nielsen LH; Keller SS; Gordon KC; Boisen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):418-25. PubMed ID: 22521331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin.
    Bhugra C; Shmeis R; Pikal MJ
    J Pharm Sci; 2008 Oct; 97(10):4446-58. PubMed ID: 18228583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of counterion on the phase behaviour during lyophilization of indomethacin salt forms.
    Kumar L; Baheti A; Mokashi A; Bansal AK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):136-41. PubMed ID: 21767640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
    Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
    AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Effect of the Preparation Method and Compression on the Physical Stability and Dissolution Behavior of Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Di R; Liu J; Peltonen L; Strachan CJ; Rades T; Gordon KC
    Mol Pharm; 2021 Mar; 18(3):1408-1418. PubMed ID: 33586988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compression-induced crystallization of amorphous indomethacin in tablets: characterization of spatial heterogeneity by two-dimensional X-ray diffractometry.
    Thakral NK; Mohapatra S; Stephenson GA; Suryanarayanan R
    Mol Pharm; 2015 Jan; 12(1):253-63. PubMed ID: 25438193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.